The direct-to-consumer tests are the personalised biomedical and genetic diagnostics sold directly to consumers without the involvement of healthcare professions. The direct-to-consumer test kits are sold via online websites, televisions or other portals.
Cheek swab or urine samples are collected at-home and reports are delivered online or mailed. Direct-to-consumer tests covers a vast array of genetic testing, estimating genetic predisposition to diseases such as cancer, determination of protein level in the body, toxins in urine and analysis of microbiome or microbial flora.
Majority of direct-to-consumer tests are utilised for genetic tastings. The direct-to-consumer tests provide data such as disease risk estimation, ancestry, ethnicity, paternity and to unravel a better lifestyle.
In the testing, 600,000 single nucleotides polymorphic site. According to the MIT technology review, 26 million people have used direct-to-consumer tests. The global market is poised to grow with the increasing awareness, demands for personalised direct-to-consumer testing kits and increasing disorders.
Coronavirus has a propelled the global market of the direct-to-consumer test due to its benefits of collection of sample and at-home test which reduces the risk of virus transmission for disease diagnosis.
The global direct-to-consumer tests market is driven by the increasing awareness, curiosity to determine diseases and genetic identity, propelling research, along with the high convenient service, availability and affordability through online portals, demand and high disposable incomes.
The direct-to-consumer tests kits are in high-end demand for studies including genetic diseases, nutrigenomics, predictive analysis and ancestral studies. The recent technological advancements have fast paced of the genetic information decoding within small budget and time.
The manufactures are developing direct-to-consumer tests kits with the prime focus on improved efficiency, accuracy and affordability. testing with deliberated efforts on increasing sales with the promotions and discounts via online and retail channels.
However, there are certain restraining factors decelerated the growth spurt of global direct-to-consumer tests. The direct-to-consumer tests are criticized and questioned for their clinical validations, utility, ethical issues of the genetic findings and additional cost for follow-up tests.
Although, the overall global market of direct-to-consumer tests is expected to grow lucratively with the rising awareness, convenient testing and report delivery, availability of direct-to-consumer tests with improved efficacy and affordability.
The global direct-to-consumer tests market is expected to register a healthy growth driven by the rising awareness advancing research and convenient services of direct-to-consumer tests market and high disposable incomes to consumers for personalised direct-to-consumer testing kits.
By testing types genetic disease carrier and predictive testing dominates the testing segment of the direct-to-consumer tests driven by the increasing awareness of genetic diseases and its diagnosis with the direct-to-consumer tests.
The curiosity to find out the possibility of carrying any genetic and lifestyle diseases also for safer pregnancy is the major paradigm of dominance. By technology single nucleotide polymorphism rules the technology segment of the direct-to-consumer tests with its wide applications in susceptibility to certain diseases such as asthma diabetes drugs and other studies with affordability.
By distribution channel online platforms hold the largest segment due to the attractive discounts and offer along with the convenience of at-home sample collection easy accessibility on Smartphones and online report delivery.
North America holds the largest global direct-to-consumer tests market due to the increasing disposable incomes which encourage the consumer towards the curiosity-driven expenditure on nutrigenomics ancestral links cancer determination of Alzheimer’s diseases and key players advancing technology and services.
Europe holds the second largest market of direct-to-consumer tests with the awareness advancing technology and demands of personalized direct-to-consumer tests kits. Asia-pacific direct-to-consumer tests market has registered a boosting growth spurt driven by the research and technological advancements vast availability of direct-to-consumer testing kits for disease diagnosis and increasing per capita income of China Japan and India.
Latin America direct-to-consumer tests market is expected to grow with the improving disposable incomes and direct-to-consumer tests availability in developing nation such as Brazil and Mexico. MEA & Africa direct-to-consumer tests market is growing gradually with the progressing research and increasing use in the ancestry and biomedical diagnosis purposes.
The global direct-to-consumer tests market is segmented into testing types, technology, distribution channels and regions
Testing Types
Technology
Distribution Channels
Explore Similar Insights
Direct-To-Consumer Test Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
